When a compassionate community of supporters joins forces with a dedicated team to eliminate preventable blindness, the results are extraordinary. Thanks to your unwavering support, tens of thousands of people regained their sight – bringing hope, possibilities, and brighter futures to communities worldwide.
Here are just a few highlights from 2024 that you made possible:
Continue reading
Matt Damon and Misty Copland, would you mind scooting over? Yes, you may take your award with you. Oh this? Well, we have an award too. Let’s do lunch.
Fine, so we didn’t actually meet our fellow Anthem Award winners. Nonetheless, we’re proud to be among the ranks of people and worldwide organizations whose mission-driven work is acknowledged. In January, Seva was recognized in the categories of Health, Product and Service for the Pristine 5.0 camera (formerly Vistaro).
Continue reading
From education to eyeglasses, from cataract surgery to cameras that diagnose, your support has helped people around the world. Thanks to you, Seva has provided vital eye care services to 57 million people in the world, including more than 6.5 million people in the last year alone. Seva’s vision is a world in which no one lives with avoidable blindness.
Continue reading
As a global public health organization, we experience all sorts of obstacles in our pursuit of bringing equitable eye care to communities where it is most needed: geographic isolation, economic insecurity, and even war, to name a few. With your support, we work to overcome these barriers – and travel that last mile.
Continue reading
You just helped us turn a page in diagnosing eye diseases. You may remember, Seva, in partnership with Remidio Innovative Solutions, developed Pristine 5.0 Retinal Camera (formerly Vistaro) – a revolutionary, wide-field retinal camera that transforms how clinics diagnose conditions affecting the back of the eye.
Why is Pristine 5.0 so important? Most medical devices that image the back of the eye are out of reach for communities. This leaves many blindness-causing infections, including CMV retinitis – commonly found in those living with HIV – to go undiagnosed. Pristine 5.0 is cost-effective, portable, and durable – it could help reduce AIDS-related blindness by half!
We’ve heard from our partners in Ukraine, Mozambique & India who’ve been field-testing the camera – and it’s already making waves in the community. As a Seva supporter, you have played an important part in helping to make this moment in eye tech history possible.
Continue reading
You read that right, nonprofits. We know nonprofits don’t often come top of mind as being “disruptive,” but we’re here to paint a new picture. Compassion has always been an important driver of innovation at Seva.
At Seva, we invest in a suite of cutting-edge and revolutionary technologies to create a world free of avoidable blindness. Leveraging millions of data points, four decades of experience, and a network of leading public health experts, engineers, and physicians, our best-in-class tech solutions revolutionize the way eye care is delivered worldwide.
“We operate at the scale of a major corporation and the nimbleness of a start-up. Straddling this balance is disrupting the future of ophthalmology and public health – for good”.
– Kate Moynihan, Executive Director, Seva Foundation.
For over four decades, Seva has been on the cutting edge of innovative humanitarian eye care. Today, our AIDS Eye Initiative stands on the cusp of another exciting breakthrough: a camera that can quickly and easily detect blindness-causing infections and life-threatening Tuberculosis in people living with AIDS. Most of these 38 million people live in low and middle income countries with weak health care systems.
Continue reading* We won't share your email and you can unsubscribe at any time.
Contact Us Search State Disclosures Privacy Policy Job Opportunities Sign In
Seva Foundation 1786 Fifth Street Berkeley, CA 94710 phone: 510-845-7382 fax: 510-845-7410
Seva Foundation is a 501(c)(3) not-for-profit organization. ©2021 Seva Foundation. All rights reserved.